Table 5.
Linear Regression Predicting HRH from Significant Associates Among Adolescents with Cancer
| Predictors | b (SE) | β | p |
|---|---|---|---|
| Step 1: Demographic covariates | |||
| Sex | 0.65 (0.29) | 0.22 | 0.03 |
| Step 2: Disease-related variables | |||
| Sex | 0.44 (0.25) | 0.15 | 0.08 |
| Pain severity (last 4 weeks) | 0.36 (0.11) | 0.33 | 0.001 |
| Fatigue HRQOL | −0.02 (0.01) | −0.25 | 0.03 |
| Nausea HRQOL | −0.01 (0.01) | −0.10 | 0.27 |
| Cognitive problems HRQOL | −0.00 (0.01) | −0.01 | 0.87 |
| Step 3: Psychosocial factors | |||
| Sex | 0.52 (0.24) | 0.18 | 0.03 |
| Pain severity | 0.42 (0.11) | 0.39 | <0.001 |
| Fatigue HRQOL | −0.01 (0.01) | −0.19 | 0.09 |
| Nausea HRQOL | −0.01 (0.01) | −0.13 | 0.14 |
| Cognitive problems HRQOL | 0.00 (0.01) | 0.02 | 0.83 |
| Caregiver-reported family functioning | 0.72 (0.26) | 0.23 | 0.01 |
Note: Italicized p-values are statistically significant.
Male is the reference group for the sex variable. Unstandardized (b) and standardized (β) betas are reported. Step 1 ΔR2 = 0.05, p = 0.03; Step 2 ΔR2 = 0.31, p < 0.001; Step 3 ΔR2 = 0.05, p = 0.01; and Total R2 = 0.41.